4
Changes in Ownership
REGENXBIO Inc. Filed Acc 0001562180-19-002005
President and CEO sold 15,000 shares at an average $58.53 ($877,989)
- President and CEO acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Mills Kenneth T. · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-19 | Exercise or conversion : show line 1 in the form | +15,000 | $0.85 | $12,750 | 261,000 | D |
| 2019-03-19 | Sale : show line 2 in the form | −5,870 | $58.21 | $341,693 | 255,130 | D |
| 2019-03-19 | Sale : show line 3 in the form | −9,130 | $58.74 | $536,296 | 246,000 | D |
| Open-market sales · 15,000 sh · avg $58.53 · $877,989 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-03-19 | Exercise or conversion : show line 4 in the form Employee Stock Option (Right to Buy) | −15,000 | $0.85 | 2024-09-23 | 15,000 | 159,670 | D |
Loading xslF345X03/primarydocument.xml…